Spots Global Cancer Trial Database for A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors
Official Title: A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors
Study ID: NCT01478685
Study Description
Brief Summary: The purpose of the study is to evaluate the safety and to define the Maximal Tolerated Dose (MTD) or the Maximal Administered Dose (MAD) of oral azacitidine as a single agent and in combination with carboplatin (CBDCA) or paclitaxel protein bound particles (ABI-007,ABX) in subjects with relapsed or refractory solid tumors.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Scottsdale Healthcare Research Institute, Scottsdale, Arizona, United States
University of California, San Francisco, San Francisco, California, United States
Indiana University Cancer Center, Indianapolis, Indiana, United States
Karmanos Cancer Institute, Detroit, Michigan, United States
Greenville Hospital, Greenville, South Carolina, United States
Sarah Cannon Research Institute, Nashville, Tennessee, United States
South Texas Accelerated Research Therapeutics, San Antonio, Texas, United States
Centre Georges Francois Leclerc, Dijon, , France
Institut Curie, Paris, , France
The Netherlands Cancer Instiute Antoni Van Leeuwenhoekziekenhuis, Amsterdam, , Netherlands
Erasmus Medical Center, Rotterdam, , Netherlands
Hospital General Universitario Gregorio Maranon, Madrid, , Spain
Hospital Universitario 12 de Octubre, Madrid, , Spain
Contact Details
Name: Gordan Bray, M.D., Ph.D
Affiliation: Celgene
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
